Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITPR3 | Q14573 | 8/20 | 1.00 |
| ▸ | ITPR2 | Q14571 | 4/20 | 0.94 |
| ▸ | ITPR1 | Q14643 | 4/20 | 0.94 |
| ▸ | INPP5A | Q14642 | 2/20 | 0.80 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.80 |
| ▸ | AKT1 | P31749 | 1/20 | 0.80 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Atrinositol SCHEMBL355653 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL888326 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL636077 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL9489238 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL9022890 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL30474862 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL29370539 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL134177 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL26683544 | 0.97 | ITPR3 (0.95) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| SCHEMBL9094714 | 0.97 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2282 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569555-B2 | Organically modified mineral micro-particles, methods of preparing the same and uses thereof | CRODA INTERNATIONAL PLC (GB) | 2026-03-10 | — | — | US | claimed |
| US-12564486-B2 | Devices and methods for treating an aneurysm | MERLIN MD PTE LTD. (SG) | 2026-03-03 | — | — | US | claimed |
| US-20260036593-A1 | DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS | UNIV CALIFORNIA (US) | 2026-02-05 | — | — | US | claimed |
| US-20250215028-A1 | SYNTHETIC GLYCEROPHOSPHOLIPIDS COMPRISING AT LEAST ONE REACTIVE FUNCTION, PROCESS FOR PREPARING SAME AND USES THEREOF IN DIFFERENT APPLICATIONS | UNIVERSITE DE ROUEN-NORMANDIE (FR) | 2025-07-03 | — | — | US | claimed |
| EP-4499652-A1 | SYNTHETIC GLYCEROPHOSPHOLIPIDS COMPRISING AT LEAST ONE REACTIVE FUNCTION, PROCESS FOR PREPARING SAME AND USES THEREOF IN DIFFERENT APPLICATIONS | Universite de Rouen Normandie (FR) | 2025-02-05 | — | — | EP | claimed |
| US-20240159774-A1 | DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-05-16 | — | — | US | claimed |
| WO-2023180457-A1 | SYNTHETIC GLYCEROPHOSPHOLIPIDS COMPRISING AT LEAST ONE REACTIVE FUNCTION, PROCESS FOR PREPARING SAME AND USES THEREOF IN DIFFERENT APPLICATIONS | UNIVERSITE DE ROUEN-NORMANDIE (FR) | 2023-09-28 | — | — | WO | claimed |
| EP-2833837-B1 | DEVICES FOR TREATING AN ANEURYSM | MERLIN MD PTE LTD (SG) | 2023-03-29 | — | — | EP | claimed |
| EP-4144351-A1 | HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVES AS INHIBITORS OF THE PROSTAGLANDIN F RECEPTOR | ObsEva S.A. (CH) | 2023-03-08 | — | — | EP | claimed |
| EP-4140988-A1 | L-VALINATE OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF | Merck Serono S.A. (CH) | 2023-03-01 | — | — | EP | claimed |
| EP-0359256-B1 | THE USE OF INOSITOLTRISPHOSPHATE IN THE TREATMENT OF TISSUE DAMAGE | PERSTORP AB (SE) | 1993-01-20 | — | — | EP | claimed |
| EP-0359259-B1 | THE USE OF INOSITOLTRISPHOSPHATE FOR THE PREPARING OF A MEDICAMENT AGAINST TRANSPLANTATION DISORDERS | PERSTORP AB (SE) | 1992-08-19 | — | — | EP | claimed |
| US-5128332-A | Method of treating cardiovascular diseases using inositoltrisphosphate | PERSTORP AB (SE) | 1992-07-07 | — | — | US | claimed |
| WO-1992000079-A1 | THE USE OF INOSITOLTRISPHOSPHATE FOR THE PREPARING OF MEDICAMENTS | PERSTORP AB (SE) | 1992-01-09 | — | — | WO | claimed |
| US-5057507-A | Method of alleviating bone damage with inositoltriphosphate | PERSTORP AB (SE) | 1991-10-15 | — | — | US | claimed |
| EP-0359258-A2 | The use of inositoltrisphosphate for the preparing of a medicament against bone disorders | PERSTORP AB (SE) | 1990-03-21 | — | — | EP | claimed |
| EP-0359259-A2 | The use of inositoltrisphosphate for the preparing of a medicament against transplantation disorders | PERSTORP AB (SE) | 1990-03-21 | — | — | EP | claimed |
| EP-0359257-A2 | Use of inositol triphosphate in the preparation of a medicament against diabetes | PERSTORP AB (SE) | 1990-03-21 | — | — | EP | claimed |
| EP-0359260-A2 | The use of inositoltrisphosphate for the preparing of a medicament against abnormal levels of lipoproteins | PERSTORP AB (SE) | 1990-03-21 | — | — | EP | claimed |
| EP-0359256-A2 | The use of inositoltrisphosphate in the treatment of tissue damage | PERSTORP AB (SE) | 1990-03-21 | — | — | EP | claimed |